Nancy Agmon-Levin is an expert in Immunology at Sheba Medical Center (Israel). As of October 2026, ScienceLeadR ranks Nancy Agmon-Levin in the top 1% of experts worldwide for Autoimmune Diseases. Nancy Agmon-Levin has authored 296 publications, the most recent in 2026, and is an investigator in 4 clinical trials. SLR score: 949 (community average: 125). How the SLR is computed.

LeadR Profile

Nancy Agmon-Levin Sheba Medical Center Israel
949 ScienceLeadR Reputation 949
Network Map

Immunology

Subspecialties: Ophthalmology - Pediatrics - Rheumatology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2004 - 2026

Source: PubMed

Sheba Medical Center

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 296

Citations

Citations: 17 632 1st author: 41 Last author: 43 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Corneal Pathologies in Patients with Thyroid Eye Disease: Prevalence, Clinical Characteristics and Treatment.
PMID 42954102 — eye, ophthalmology, pathology, thyroid gland, corneal opacity, prevalence, graves ophthalmopathy, eye diseases, therapeutics
Curr Eye Res20260
Longitudinal follow-up of autoimmune neutropenia in adults-a single-cohort experience.
PMID 42923408 — neutropenia, immunity, therapeutics, cytopenia
Front Immunol20260
Is age a critical factor for the diagnosis of peanut allergy in children?
PMID 42741213 — skin, hypersensitivity, anaphylaxis, food, peanut hypersensitivity, diagnosis, child, allergy
World Allergy Organ J20260
Antiphospholipid syndrome in the paediatric population: performance of ACR-EULAR classification criteria in a controlled cohort.
PMID 42373137 — classification, lupus erythematosus, systemic, antiphospholipid syndrome, diagnosis
Lupus Sci Med20261
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trials.
PMID 42318595 — safety, angioedemas, hereditary, aged, therapeutics, angioedema
World Allergy Organ J20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 3
Phase 3 1

By status:

Completed 4

By type:

Interventional 2
Observational 2

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 0
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 4

LeadR Networks

Main global connection map